555 active trials 316 recruiting 28 Phase 3 309 sponsors 73 changes in 30 days
| Early Phase 1 | 10 | |
| Phase 1 | 60 | |
| Phase 1/2 | 35 | |
| Phase 2 | 117 | |
| Phase 2/3 | 6 | |
| Phase 3 | 22 | |
| Phase 4 | 6 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07189897 | Apixaban or Enoxaparin After Head and Neck Cancer Surgery | Kiranya Arnold | Recruiting | 2025-10-08 |
| NCT06734598 | Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with… | National Taiwan University Hospital | Recruiting | 2024-12-16 |
| NCT07697287 | Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An… | McMaster University | Active, Not Recruiting | 2026-07-13 |
| NCT07635420 | Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical… | Region Skane | Not Yet Recruiting | 2026-06-09 |
| NCT06879691 | A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous… | Biotech Pharmaceutical Co., Ltd. | Active, Not Recruiting | 2025-03-17 |
| NCT06807034 | Impact of the Oral Microbiota on Relapse in HNSCC Patients | Institut Sainte Catherine | Active, Not Recruiting | 2025-02-04 |
| Phase 3 | ||||
| NCT04178174 | Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer | Centre hospitalier de l'Université de Montréal (CHUM) | Recruiting | 2026-08-24 |
| NCT06998069 | Head and Neck Cancer Study Project in the Geriatric Population | Brown University | Recruiting | 2026-08-20 |
| NCT07441681 | Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and… | NRG Oncology | Recruiting | 2026-08-17 |
| NCT06589804 | Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… | National Cancer Institute (NCI) | Recruiting | 2026-08-05 |
| NCT07276399 | A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… | Janssen Research & Development, LLC | Recruiting | 2026-07-31 |
| NCT06641791 | Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in… | Canadian Cancer Trials Group | Recruiting | 2026-07-14 |
| NCT07672236 | A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in… | OncoZenge AB | Recruiting | 2026-07-13 |
| NCT06525220 | A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in… | Merus B.V. | Recruiting | 2026-06-02 |
| NCT05815927 | Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | European Organisation for Research and Treatment of Cancer - EORTC | Recruiting | 2026-05-28 |
| NCT07264075 | Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus… | Groupe Oncologie Radiotherapie Tete et Cou | Recruiting | 2026-05-20 |
| NCT06992427 | High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral… | Alliance for Clinical Trials in Oncology | Recruiting | 2026-05-11 |
| NCT07467083 | Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for… | West China Hospital | Recruiting | 2026-04-01 |
| NCT06248996 | a Multicentre Phase III Study of Risk-based Treatment Intensification With… | Lund University Hospital | Recruiting | 2024-09-19 |
| NCT05273307 | Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving… | University of California, San Francisco | Active, Not Recruiting | 2026-08-11 |
| NCT05078047 | Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3… | UNICANCER | Active, Not Recruiting | 2026-07-17 |
| NCT07667296 | APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma | Aveta Biomics, Inc. | Not Yet Recruiting | 2026-07-01 |
| NCT04590963 | Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus… | AstraZeneca | Active, Not Recruiting | 2026-06-01 |
| NCT01266044 | Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia | M.D. Anderson Cancer Center | Active, Not Recruiting | 2026-04-16 |
| NCT06790966 | Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck… | PDS Biotechnology Corp. | Active, Not Recruiting | 2026-04-06 |
M.D. Anderson Cancer Center (20) · Memorial Sloan Kettering Cancer Center (11) · National Cancer Institute (NCI) (11) · West China Hospital (9) · University Health Network, Toronto (8) · Dana-Farber Cancer Institute (7) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (6) · University of Chicago (6) · University of Colorado, Denver (6) · Roswell Park Cancer Institute (5)